1,401,944 filings since 2004 · latest accepted Nov 4, 2026, 6:08 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
May 13, 2025 accepted 4:26 PM ET | TVRDTvardi Therapeutics, Inc. | 2.02Earnings release4.01Auditor change | DocumentSEC ↗ |
Apr 15, 2025 accepted 4:06 PM ET | TVRDTvardi Therapeutics, Inc. | Material agreement |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Dec 18, 2024 accepted 7:23 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement5.01Change in control5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Nov 22, 2024 accepted 4:09 PM ET | TVRDTvardi Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Aug 1, 2024 accepted 4:15 PM ET | TVRDTvardi Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jun 18, 2024 accepted 4:16 PM ET | TVRDTvardi Therapeutics, Inc. | 2.05Restructuring costs | DocumentSEC ↗ |
Feb 2, 2024 accepted 4:59 PM ET | TVRDTvardi Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 22, 2024 accepted 4:19 PM ET | TVRDTvardi Therapeutics, Inc. | 2.05Restructuring costs7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |